Cargando…

Primary Prophylaxis of Overt Hepatic Encephalopathy: Is It Time to Consider It?

Detalles Bibliográficos
Autores principales:	Faccioli, Jessica, Nardelli, Silvia, Gioia, Stefania, Riggio, Oliviero, Ridola, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298885/ https://www.ncbi.nlm.nih.gov/pubmed/37373598 http://dx.doi.org/10.3390/jcm12123903

Ejemplares similares

Hepatic Encephalopathy: Diagnosis and Management
por: Ridola, Lorenzo, et al.
Publicado: (2020)

Minimal hepatic encephalopathy and sleep disorders in patients with cirrhosis: Which comes first?
por: Ridola, Lorenzo, et al.
Publicado: (2020)

Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy
por: Nardelli, Silvia, et al.
Publicado: (2019)

Minimal Hepatic Encephalopathy Affects Daily Life of Cirrhotic Patients: A Viewpoint on Clinical Consequences and Therapeutic Opportunities
por: Faccioli, Jessica, et al.
Publicado: (2022)

Quality of life in patients with minimal hepatic encephalopathy
por: Ridola, Lorenzo, et al.
Publicado: (2018)

Old and New Precipitants in Hepatic Encephalopathy: A New Look at a Field in Continuous Evolution
por: Bellafante, Daniele, et al.
Publicado: (2023)

Determinants of prognosis in cirrhosis: a new outlook
por: Ridola, Lorenzo, et al.
Publicado: (2022)

Neurological and psychiatric effects of hepatitis C virus infection
por: Faccioli, Jessica, et al.
Publicado: (2021)

The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
por: Gioia, Stefania, et al.
Publicado: (2021)

Ammonia and the Muscle: An Emerging Point of View on Hepatic Encephalopathy
por: Di Cola, Simone, et al.
Publicado: (2022)

Hepatic Encephalopathy in the 21st Century: Still an Emerging Topic
por: Ridola, Lorenzo, et al.
Publicado: (2021)

Cognitive Impairement in Non-Cirrhotic Portal Hypertension: Highlights on Physiopathology, Diagnosis and Management
por: Gioia, Stefania, et al.
Publicado: (2021)

Nutrition Assessment and Management in Patients with Cirrhosis and Cognitive Impairment: A Comprehensive Review of Literature
por: Faccioli, Jessica, et al.
Publicado: (2022)

Transjugular Intrahepatic Portosystemic Shunt Placement: Effects on Nutritional Status in Cirrhotic Patients
por: de Felice, Ilaria, et al.
Publicado: (2023)

Causes and Management of Non-cirrhotic Portal Hypertension
por: Gioia, Stefania, et al.
Publicado: (2020)

Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms
por: Nardelli, Silvia, et al.
Publicado: (2019)

The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies
por: Ridola, Lorenzo, et al.
Publicado: (2018)

Is porto sinusoidal vascular disease to be actively searched in patients with portal vein thrombosis?
por: Gioia, Stefania, et al.
Publicado: (2019)

Identifying Patients at High Risk of Developing Non-Cirrhotic Portal Hypertension
por: Gioia, Stefania, et al.
Publicado: (2021)

Spontaneous porto-systemic shunts in liver cirrhosis: Clinical and therapeutical aspects
por: Nardelli, Silvia, et al.
Publicado: (2020)

Small hepatic veins Budd-Chiari syndrome and paroxysmal nocturnal hemoglobinuria - The association of two rare entities: a case report
por: Gioia, Stefania, et al.
Publicado: (2020)

Rifaximin as Treatment for Hepatic Encephalopathy: Some Considerations
por: Ridola, Lorenzo, et al.
Publicado: (2013)

Usefulness of the Stroop Test in Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy
por: Hanai, Tatsunori, et al.
Publicado: (2021)

Overt hypothyroidism in pregnancy: Can we consider medical termination of pregnancy?
por: Kalra, Sanjay, et al.
Publicado: (2013)

Predicting overt hepatic encephalopathy after TIPS: Value of three minimal hepatic encephalopathy tests
por: Ehrenbauer, Alena F., et al.
Publicado: (2023)

Non-invasive tests for fibrosis detection: still in search for the best way
por: Ridola, Lorenzo, et al.
Publicado: (2022)

Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs
por: Roggeri, Daniela Paola, et al.
Publicado: (2015)

Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis
por: Gairing, Simon J., et al.
Publicado: (2023)

Animal Naming Test – a simple and accurate test for diagnosis of minimal hepatic encephalopathy and prediction of overt hepatic encephalopathy
por: Agarwal, Ankit, et al.
Publicado: (2020)

Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis
por: Wernberg, Charlotte W., et al.
Publicado: (2019)

Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin
por: Neff, Guy, et al.
Publicado: (2018)

Overt Hepatic Encephalopathy Experienced by Individuals With Cirrhosis: A Qualitative Interview Study
por: Ladegaard Grønkjær, Lea, et al.
Publicado: (2018)

Neuroprotective Effect of Nortriptyline in Overt Hepatic Encephalopathy Through Attenuation of Mitochondrial Dysfunction
por: Jeong, Ji Heun, et al.
Publicado: (2018)

The Role of Presepsin in Diagnosing Infections in Patients with Liver Cirrhosis and Overt Hepatic Encephalopathy
por: Igna, Razvan, et al.
Publicado: (2022)

Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study
por: Riggio, Oliviero, et al.
Publicado: (2023)

An educational tool for the prophylaxis of hepatic encephalopathy
por: Garrido, Maria, et al.
Publicado: (2017)

Correction to: Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin
por: Neff, Guy, et al.
Publicado: (2018)

Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis
por: Bai, Zhaohui, et al.
Publicado: (2019)

The Efficacy of Levocarnitine Treatment in Relieving Fatigue in Patients with Cirrhosis but without Overt Hepatic Encephalopathy
por: Abe, Kazumichi, et al.
Publicado: (2021)

Effect of Selenium Deficiency on the Development of Overt Hepatic Encephalopathy in Patients with Chronic Liver Disease
por: Nakahata, Yuki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o9fle8a5maqa8uuapkcdtg08ra